Rare lephants
Screener

Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Aug 30, 2021 FORM 4 SUBMISSION
4 Aug 30, 2021 FORM 4 SUBMISSION
4 Aug 30, 2021 FORM 4 SUBMISSION
4 Aug 30, 2021 FORM 4 SUBMISSION
4 Aug 30, 2021 FORM 4 SUBMISSION
8-K Aug 30, 2021 8-K
4 Aug 27, 2021 PRIMARY DOCUMENT
4 Aug 24, 2021 PRIMARY DOCUMENT
4 Aug 18, 2021 FORM 4 SUBMISSION
4 Aug 18, 2021 FORM 4 SUBMISSION
4 Aug 18, 2021 FORM 4 SUBMISSION
4 Aug 18, 2021 FORM 4 SUBMISSION
4 Aug 18, 2021 FORM 4 SUBMISSION
4 Aug 18, 2021 FORM 4 SUBMISSION
8-K Aug 18, 2021 8-K
4 Aug 18, 2021 FORM 4 SUBMISSION
8-K Aug 5, 2021 8-K
10-Q Aug 5, 2021 10-Q
D Jul 14, 2021
SC 13G Jul 9, 2021 SC 13G SPERO THERAPEUTICS, INC.
DEF 14A Jul 6, 2021 DEF 14A
8-K Jul 1, 2021 8-K
PRE 14A Jun 25, 2021 PRE 14A
8-K May 6, 2021 8-K
10-Q May 6, 2021 10-Q Q1 2021
← Newer Page 11 of 21 · 513 filings Older →